aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
From TechCrunch
By Marina Temkin
June 6, 2024
Over half of Americans wear corrective glasses or contact lenses. While there isn’t a shortage of low-cost and luxury frames available online or in stores, consumers can only buy them with a current eyeglass prescription.
That means that they first need an eye exam from an optometrist to receive that prescription. But, due to a nationwide shortage of eye care practitioners, it may take weeks, especially in rural areas, to get an appointment.
Eyebot, a new startup coming out of stealth on Thursday, wants to reduce the time it takes to receive an eye exam to about 90 seconds without the direct involvement of an optometrist. Starting in October, the Boston-based company will roll out its self-serv, vision-testing terminals in shopping centers, grocery stores and pharmacies in New England.
Anyone who wants to have their vision checked can walk up to Eyebot’s 5-ish-foot kiosk, press a button, and the company’s computer vision technology will automatically scan the person’s eyes, extracting eyeglass or contact lens prescription. (While Eyebot can’t perform initial fittings of contact lenses, it can update an existing prescription.)
Eyebot’s founder and CEO Matthias Hofmann said he developed similar technology ten years ago at EyeNetra, a startup that used smartphones to test eyesight. (EyeNetra went out of business several years ago, according to Hoffman, who worked there as the leading engineer until 2015.)
“We realized that using smartphones is not actually the solution,” said Hoffman, who, before joining EyeNetra, was a postdoctoral researcher in tomography at Harvard Medical School. “What people want is a fully automated experience where they don’t have to learn or do anything complicated. Our technology now allows people to simply stand in front of our units.”
Eyebot-generated prescriptions are finalized by teledoctors within 24 hours, and consumers who want to purchase glasses from any retailer must pay $30 for their exam. But if they purchase glasses from one of Eyebot’s partner brands, the eye exam is free. (The technology is registered with the FDA, Hoffman said.)
The company hopes that major eyeglass brands will rent Eyebot terminals and put them in the retail locations of their choice. Once a shopper finalizes their exam, they can choose to buy eyeglasses from that brand directly on a touchscreen within the kiosk or by using their smartphone. Eyebot plans to make money by partnering with these eyewear brands and taking a commission on each sale.
“Retailers are looking for new channels to reach the customers,” Hoffman said. “Now they have an opportunity to show their brand in CVS, Walgreens, Stop and Shop, Kroger and on college campuses.”
Eyebot is close to finalizing partnership agreements with several large eyeglass and contact lens merchants, Hoffman said. “It’s a very lucrative model. The demand for what we’re doing is very high.”
Demand for investing in Eyebot’s seed round was high, too, according to Hoffman. On Thursday, the company announced a $6 million funding round led by AlleyCorpand Ubiquity Ventures with participation from Susa Ventures, Village Global, Baukunst, Ravelin, and Spacecadet.
The capital will be used for expansion to geographies.
Share:
Mistral gets down to business
Hundreds of heads of states, tech CEOs and nonprofits have flocked to Paris for the Artificial Intelligence Action Summit. So far, the winner of this week’s diplomatic and business parade seems to be Mistral. In business lingo, we would say that the French AI unicorn is experiencing tailwinds. Mistral has been one of the leading artificial intelligence companies in Europe. Originally, it released some impressive open-weight models and on the back of a lot of interest in Large Language Models, G
Feb 10, 2025
Here are five startups that are running Super Bowl ads this year
Super Bowl weekend is here with the Philadelphia Eagles set to take on the Kansas City Chiefs in New Orleans on Sunday evening. While many folks tune in to the Super Bowl for the actual football, others do so for the halftime performance, and some tune in just for the ads. The ad roster this year includes many of the names one comes to expect to see at the Super Bowl, from beer companies like Budweiser and Coors to savory snack companies like Doritos. We’ll also see some ads from a handful of s
Feb 9, 2025
Anduril in talks to raise up to $2.5B at $28B valuation
Just six months after defense tech Anduril raised a massive $1.5 billion round that valued the company at $14 billion, it’s in talks to raise another $2.5 billion, at a valuation of up to $28 billion, sources told CNBC. The deal would, not surprisingly, be led by Founders Fund, which is reportedly writing a $1 billion check that represents its largest check ever. While Anduril founder Palmer Luckey is the face of the company, it names five men as co-founders, among them Founders Fund partner Tr
Feb 7, 2025
Don't miss our latest news and updates. Subscribe to the newsletter